The largest database of trusted experimental protocols

Erythrocyte lysis buffer 1

Manufactured by Miltenyi Biotec
Sourced in Italy

Erythrocyte lysis buffer 1× is a laboratory reagent used to selectively lyse red blood cells (erythrocytes) in a sample. It is a balanced salt solution that effectively removes erythrocytes, allowing for the isolation and analysis of other cell types, such as leukocytes, from a heterogeneous cell population.

Automatically generated - may contain errors

2 protocols using erythrocyte lysis buffer 1

1

Isolation and Culture of Adipose-Derived Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the samples (10 mL each) were digested with collagenase type I at the concentration of 1 mg/mL (GIBCO Life Technology, Monza, Italy) dissolved in Hank’s Balanced Salt Solution (HBSS, GIBCO Life Technology, Monza, Italy) with 2% Bovine Serum Albumin (BSA, GIBCO Life Technology, Monza, Italy) for 45 min at 37 °C. Complete culture medium (Dulbecco’s Modified Eagle’s Medium (DMEM), Sigma-Aldrich, Milan, Italy), supplemented with 10% of Fetal Bovine Serum (FBS, GIBCO Life Technologies, Waltham, MA, USA), 1% 1:1 penicillin/streptomycin (P/S solution, GIBCO Life Technologies, Waltham, MA, USA) and 0.6% Amphotericin B (GIBCO Life Technologies, Waltham, MA, USA), was added to neutralize the enzyme action. After the neutralization process, the sample was centrifuged at 3000 rpm for 5 min. The cell pellet was incubated with erythrocyte lysis buffer 1× (Macs Miltenyi Biotec, Milan, Italy) for 10 min at room temperature. Again, the cell suspension was centrifuged and resuspended in a complete culture medium. Finally, the cells were filtered through a 70 µm nylon mesh. The products obtained were then cultured for the following cellular analysis.
+ Open protocol
+ Expand
2

Enzymatic Digestion of Nanofat-Derived Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The remaining portion of lipoaspirate (10 ml) was first processed with the
Hy-Tissue Nanofat kit, followed by the treatment with
collagenase type I. The Nanofat-SVF obtained, as described section “Adipose
Tissue Collection,” was incubated with collagenase type I at a concentration of
1 mg/ml (GIBCO Life Technologies) dissolved in HBSS (GIBCO Life Technologies)
with 2% of BSA (GIBCO Life Technologies) for 45 min at 37°C. Complete culture
medium (DMEM; Sigma-Aldrich), supplemented with 10% of FBS (GIBCO Life
Technologies), 1% of 1:1 penicillin/streptomycin (P/S solution; GIBCO Life
Technologies), and 0.6% of amphotericin B (GIBCO Life Technologies), was added
to neutralize the enzyme action. After the neutralization process, the sample
was centrifuged at 3,000 × g for 5 min. The cell pellet was
incubated with 1 ml of erythrocyte lysis buffer 1× (Macs Miltenyi Biotec) for 10
min at room temperature. Again, the cell suspension was centrifuged and
resuspended with 1 ml of complete culture medium. Finally, the cells were
filtered through a 70-µm nylon mesh.
The product obtained by this method was named “enzymatic digestion of Nanofat-SVF
(N-ED-ASCs).”
Table 1 summarizes
the code names used to identify the different processes employed to treat the
fat tissue.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!